SCHEMBL6312760

SCHEMBL6312760

CCC(C)Oc1n[nH]c(=O)c2cc(Br)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.43
▸ WDR77 Q9BQA1 2/20 0.43
▸ GSK3B P49841 2/20 0.36
▸ CHEK1 O14757 2/20 0.35
▸ PIM1 P11309 2/20 0.35
▸ FLT3 P36888 2/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ LRRK2 Q5S007 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ TYMS P04818 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PIK3R1 P27986 2/20 0.34
▸ PIK3CA P42336 2/20 0.34
▸ MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26732995 0.81 PRMT5 (0.43) PRMT5WDR77GSK3BCHEK1PIM1
SCHEMBL29426590 0.81 PRMT5 (0.43) PRMT5WDR77GSK3BCHEK1PIM1
SCHEMBL26732994 0.75 PRMT5 (0.40) PRMT5WDR77GSK3BCHEK1PIM1
SCHEMBL6313685 0.73 PRMT5 (0.41) PRMT5WDR77GSK3BCHEK1PIM1
SCHEMBL17824579 0.73 PRMT5 (0.46) PRMT5WDR77GSK3BCHEK1PIM1
SCHEMBL29480940 0.73 PRMT5 (0.59) PRMT5WDR77GSK3BALDH1A1SMN1; SMN2
SCHEMBL17825064 0.73 PRMT5 (0.59) PRMT5WDR77GSK3BALDH1A1SMN1; SMN2
SCHEMBL29480982 0.73 PRMT5 (0.46) PRMT5WDR77GSK3BCHEK1PIM1
SCHEMBL29426556 0.72 PRMT5 (0.46) PRMT5WDR77GSK3BCHEK1PIM1
SCHEMBL26732891 0.72 PRMT5 (0.46) PRMT5WDR77GSK3BCHEK1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050033050-A1 Phthalazinones and the use thereof in order to combat undesirable microorganisms BAYER CROPSCIENCE AG (DE) 2005-02-10 — — US disclosed
EP-1430035-A1 PHTHALAZINONES AND THE USE THEREOF IN ORDER TO COMBAT UNDESIRABLE MICROORGANISMS Bayer CropScience AG (DE) 2004-06-23 — — EP disclosed
WO-2003024938-A1 PHTHALAZINONES AND THE USE THEREOF IN ORDER TO COMBAT UNDESIRABLE MICROORGANISMS BAYER CROPSCIENCE AG (DE) 2003-03-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033050-A1 Phthalazinones and the use thereof in order to combat undesirable microorganisms PGLS, DCXR, C5 PRMT5 170/4885WDR77 641/4885GSK3B 2646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback